Chapter 2. From microbial products to novel drugs that target a multitude of disease indications
- PMID: 19374978
- DOI: 10.1016/S0076-6879(09)04802-2
Chapter 2. From microbial products to novel drugs that target a multitude of disease indications
Abstract
More than 20,000 bioactive, so-called microbial secondary metabolites are known. In nature, they can play many different roles as antibiotics, toxins, ionophores, bioregulators, and in intra- and interspecific signaling. Their most versatile producers are differentiating filamentous fungi and actinomycetes, followed by other bacteria such as Bacillus, Pseudomonas, Myxobacteria, and Cyanobacteria. From a biotechnological point of view, bioactive metabolites have been mainly studied as potential anti-infectives (antibacterials, antifungals, antivirals, and antiparasitics). Many of them, originally discovered for their antibiotic activity, were developed further to become leading anticancer drugs, immunosuppressive agents for organ transplantation, and successful pharmaceuticals targeting metabolic and cardiovascular diseases. Old and novel antitumor antibiotics can be divided into two groups spanning diverse chemical classes: those causing some damage to the DNA such as Mitomycins (quinones), Bleomycins (glycopeptides), Actinomycins (peptides), Anthracyclines (aromatic polyketides), Pentostatin (nucleoside), Enediynes (polyketides), and Rebeccamycin derivatives (indolocarbazole glycosides)-all produced by Streptomyces strains or related genera; and the group of tubulin-targeting molecules such as plant/fungal Taxanes (terpenes), myxobacterial Epothilones (macrocyclic polyketides), and the revisited Cryptophycins (peptolides) produced by cyanobacteria. Immunosuppressive agents used in clinical practice include Cyclosporin A (cyclopeptide) and an ester of Mycophenolic acid (small aromatic polyketide), both produced by fungi, and two streptomycete macrocyclic polyketides, Sirolimus (rapamycin) and Tacrolimus (FK506). Statins include a group of fungal polyketides (Compactin or Mevastatin, Lovastatin) and their derivatives, which specifically inhibit cholesterologenesis in liver, and represent the best-selling drugs. They have been used to prevent cardiovascular diseases.
Similar articles
-
Fungal genetics, genomics, and secondary metabolites in pharmaceutical sciences.Planta Med. 2007 Feb;73(2):103-15. doi: 10.1055/s-2007-967104. Epub 2007 Jan 23. Planta Med. 2007. PMID: 17245664 Review.
-
Chemical and functional diversity of natural products from plant associated endophytic fungi.Nat Prod Commun. 2009 Nov;4(11):1511-32. Nat Prod Commun. 2009. PMID: 19967984 Review.
-
Nocardiopsins: new FKBP12-binding macrolide polyketides from an Australian marine-derived actinomycete, Nocardiopsis sp.Chemistry. 2010 Mar 8;16(10):3194-200. doi: 10.1002/chem.200902933. Chemistry. 2010. PMID: 20112311
-
A biosynthetic classification of fungal and streptomycete fused-ring aromatic polyketides.Chembiochem. 2001 Sep 3;2(9):612-27. doi: 10.1002/1439-7633(20010903)2:9<612::AID-CBIC612>3.0.CO;2-Z. Chembiochem. 2001. PMID: 11828498 Review.
-
The use of secondary metabolite profiling in chemotaxonomy of filamentous fungi.Mycol Res. 2008 Feb;112(Pt 2):231-40. doi: 10.1016/j.mycres.2007.08.018. Epub 2007 Sep 1. Mycol Res. 2008. PMID: 18319145 Review.
Cited by
-
Antibacterial Discovery and Development: From Gene to Product and Back.Biomed Res Int. 2015;2015:591349. doi: 10.1155/2015/591349. Epub 2015 Aug 3. Biomed Res Int. 2015. PMID: 26339625 Free PMC article. Review.
-
Fungal polyketide synthase product chain-length control by partnering thiohydrolase.ACS Chem Biol. 2014 Jul 18;9(7):1576-86. doi: 10.1021/cb500284t. Epub 2014 May 29. ACS Chem Biol. 2014. PMID: 24845309 Free PMC article.
-
Pep2Path: automated mass spectrometry-guided genome mining of peptidic natural products.PLoS Comput Biol. 2014 Sep 4;10(9):e1003822. doi: 10.1371/journal.pcbi.1003822. eCollection 2014 Sep. PLoS Comput Biol. 2014. PMID: 25188327 Free PMC article.
-
Bacterial Responses and Genome Instability Induced by Subinhibitory Concentrations of Antibiotics.Antibiotics (Basel). 2013 Mar 14;2(1):100-14. doi: 10.3390/antibiotics2010100. Antibiotics (Basel). 2013. PMID: 27029295 Free PMC article. Review.
-
Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant Acinetobacter baumannii.Front Cell Infect Microbiol. 2019 Jan 4;8:438. doi: 10.3389/fcimb.2018.00438. eCollection 2018. Front Cell Infect Microbiol. 2019. PMID: 30662875 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical